Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03141255 · ClinicalTrials.gov registry record · NA
Cardiogenic Shock Intravascular Cooling Trial
A NA study, sponsored by University of Chicago.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT03141255: Completed NA study, sponsored by University of Chicago.
NCT03141255 is a NA study that has completed, run by University of Chicago. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03141255, a NA study, has completed, sponsored by University of Chicago.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of the study is to compare patients with cardiogenic shock who receive standard therapy plus therapeutic hypothermia (TH) to patients with cardiogenic shock who receive standard medical therapy alone in order to assess the safety of TH in patients with cardiogenic shock. This study will also help understand the physiologic effects of TH in patients with cardiogenic shock. This will be a pilot study to establish the initial safety of TH and to assess tolerability of TH in this patient population.
Primary Outcome
requiring intervention (medical therapy or therapy with temporary pacemaker)
Interventions
- DEVICE IVTM™ System
- DEVICE Quattro® Catheter
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2017-11-06 |
| Est. Completion | 2021-11-01 |
| Phase | NA |
What the finished NCT03141255 record still lists
NCT03141255 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which IVTM™ System is the first listed.
NCT03141255 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03141255 about?
NCT03141255 is a clinical study titled "Cardiogenic Shock Intravascular Cooling Trial". The purpose of the study is to compare patients with cardiogenic shock who receive standard therapy plus therapeutic hypothermia (TH) to patients with cardiogenic shock who receive standard medical therapy alone in order to assess the safety of TH in patients with cardiogenic shock. This study will ...
What is the current status of trial NCT03141255?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2017-11-06. Estimated completion is 2021-11-01.
What interventions are being tested in trial NCT03141255?
The interventions under investigation include: IVTM™ System (DEVICE), Quattro® Catheter (DEVICE).
Who is sponsoring clinical trial NCT03141255?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03141255's enrollment target sits among peer trials
20 1768th of 2000 higher than 140 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI